Yes, Ofloxacin ophthalmic solution can be safely administered to a 5-year-old child.
Ofloxacin ophthalmic solution is FDA-approved for use in children aged 1 year and older, making it appropriate for a 5-year-old. 1
Key Safety Information
The FDA drug label explicitly states that "safety and effectiveness in infants below the age of one year have not been established," which means it is considered safe for children 1 year and older 1. Since your patient is 5 years old, they are well within the approved age range.
Important Considerations About Quinolone Safety in Children
While systemic quinolones have raised concerns about arthropathy (joint damage) in immature animals, the ophthalmic formulation has not shown any effect on weight-bearing joints 1. The FDA label specifically notes: "topical ocular administration of ofloxacin to immature animals has not shown any arthropathy. There is no evidence that the ophthalmic dosage form of ofloxacin has any effect on weight bearing joints" 1.
This distinction is critical—the arthropathy concerns apply to oral/systemic quinolones, not topical ophthalmic use.
Clinical Context from Guidelines
The 2024 Bacterial Keratitis Preferred Practice Pattern guideline supports fluoroquinolone use (including ofloxacin 0.3%) as FDA-approved treatment for bacterial keratitis, without age restrictions beyond infancy 2. Ofloxacin 0.3% is specifically mentioned as one of three FDA-approved fluoroquinolones for bacterial keratitis treatment 2.
Practical Dosing Considerations
- Use the same concentration (0.3%) as in adults
- No dose adjustment is needed based on the child's age or weight for topical ophthalmic administration
- Standard dosing frequency applies (typically every 2-4 hours while awake for bacterial conjunctivitis, more frequent for keratitis)